Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Free vs Multimodal Anesthesia in Gastric Bypass
NCT05004519Completed
- Start
- Oct 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in class III obesity (2 arms). Primary endpoint: Total Morphine consumption at 24 hours. Started Oct 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
class III obesity
Beyond the preview
Go deeper on NCT05004519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05004519.